BiliCam Clinical Validation Study

Completed

Conditions studied: Newborn Jaundice

In brief

The goal of this study is to assess the accuracy of BiliCam, a non-invasive technology based on analysis of digital images obtained with an app installed on a commercial smartphone, in estimating total serum bilirubin levels in newborns. BiliCam estimated bilirubin levels will be compared to total serum bilirubin levels in up to 225 newborns.

Key facts

Study ID

NCT03246503

Run by

BiliCam, LLC

People needed

203

Starts

2017-08-21

Expected to finish

2018-04-30

Last updated by the study team

2022-06-09

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Newborn born at ≥ 35 weeks gestation
• Parent speaks and reads English
• Parent provides written informed consent

You may not qualify if…

• previous or ongoing treatment with phototherapy for hyperbilirubinemia
• Medical or other complications that preclude completion of the study

Where it is running

• Thomas Jefferson University Hopsital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.